IART - Company ID 0000917520
The table below shows INTEGRA LIFESCIENCES HOLDINGS CORP's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $9.80M | -$11.26M | $15.76M | $26.16M | $44.34M | $69.08M |
| Capital expenditure | $14.85M | $28.92M | $15.46M | $13.70M | $9.32M | $6.67M |
| Investing cash flow | -$14.85M | -$35.92M | -$53.97M | -$13.70M | -$14.07M | -$117.57M |
| Dividends paid | - | - | - | - |
INTEGRA LIFESCIENCES HOLDINGS CORP reported operating cash flow of $50.38M for fiscal year 2025. That is down 61.1% from $129.38M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $116.41M (FY 2016) to $50.38M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | $0.00 | $150.00M | $125.00M | $0.00 |
| Financing cash flow | $8.30M | $35.38M | $358.68M | -$162.68M | -$133.47M | -$3.02M |